Cargando…

Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019

Ureaplasma spp. and Mycoplasma hominis, frequent colonizers in the lower urogenital tract, have been implicated in various infections, with antibiotic resistance growing and varying regionally. This study aims to investigate the prevalence and antibiotic resistance profiles of Ureaplasma spp. and M....

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jingjuan, Wu, Xuanlan, Kong, Yingying, Jin, Hong, Yang, Ting, Xie, Xinyou, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520197/
https://www.ncbi.nlm.nih.gov/pubmed/36187990
http://dx.doi.org/10.3389/fmicb.2022.982429
_version_ 1784799571408322560
author Song, Jingjuan
Wu, Xuanlan
Kong, Yingying
Jin, Hong
Yang, Ting
Xie, Xinyou
Zhang, Jun
author_facet Song, Jingjuan
Wu, Xuanlan
Kong, Yingying
Jin, Hong
Yang, Ting
Xie, Xinyou
Zhang, Jun
author_sort Song, Jingjuan
collection PubMed
description Ureaplasma spp. and Mycoplasma hominis, frequent colonizers in the lower urogenital tract, have been implicated in various infections, with antibiotic resistance growing and varying regionally. This study aims to investigate the prevalence and antibiotic resistance profiles of Ureaplasma spp. and M. hominis in outpatients in Hangzhou, China, from 2013 to 2019. A total of 135,263 outpatients were examined to determine the prevalence of Ureaplasma spp. and M. hominis, including 48,638 males and 86,625 females. Furthermore, trends in antibiotic susceptibility of Ureaplasma spp. and M. hominis during 1999–2019 were analyzed. The cultivation, identification, and antibiotic susceptibility of the bacteria (ofloxacin, ciprofloxacin, erythromycin, clarithromycin, azithromycin, josamycin, tetracycline, doxycycline, and pristinamycin) were determined using the Mycoplasma IST2 kit. Our study indicated that the overall prevalence of total Ureaplasma spp./M. hominis was 38.1% from 2013 to 2019. Ureaplasma spp. were the most frequently isolated species (overall prevalence, 31.3%), followed by Ureaplasma spp./M. hominis coinfection (6.0%) and single M. hominis infection (0.8%). The prevalence of Ureaplasma spp. and M. hominis was significantly higher in females than in males, and the highest positive rates of total Ureaplasma spp./M. hominis were observed in both female and male outpatients aged 14–20 years. During 2013–2019, josamycin, tetracycline, doxycycline, and pristinamycin maintained exceptionally high activity (overall resistance rates, <5%) against both Ureaplasma spp. and M. hominis, but ofloxacin and ciprofloxacin showed limited activity (overall resistance rates, >70%). During 1999–2019, the rates of resistance to ofloxacin and ciprofloxacin increased against both Ureaplasma spp. and M. hominis but decreased to erythromycin, clarithromycin, azithromycin, tetracycline, and doxycycline against Ureaplasma spp. In conclusion, our study demonstrates a high prevalence of Ureaplasma spp. compared to M. hominis and Ureaplasma spp./M. hominis, and their distribution was associated with sex and age. Josamycin, doxycycline, and tetracycline are promising antibiotics that have remarkable activity against Ureaplasma species and M. hominis.
format Online
Article
Text
id pubmed-9520197
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95201972022-09-30 Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019 Song, Jingjuan Wu, Xuanlan Kong, Yingying Jin, Hong Yang, Ting Xie, Xinyou Zhang, Jun Front Microbiol Microbiology Ureaplasma spp. and Mycoplasma hominis, frequent colonizers in the lower urogenital tract, have been implicated in various infections, with antibiotic resistance growing and varying regionally. This study aims to investigate the prevalence and antibiotic resistance profiles of Ureaplasma spp. and M. hominis in outpatients in Hangzhou, China, from 2013 to 2019. A total of 135,263 outpatients were examined to determine the prevalence of Ureaplasma spp. and M. hominis, including 48,638 males and 86,625 females. Furthermore, trends in antibiotic susceptibility of Ureaplasma spp. and M. hominis during 1999–2019 were analyzed. The cultivation, identification, and antibiotic susceptibility of the bacteria (ofloxacin, ciprofloxacin, erythromycin, clarithromycin, azithromycin, josamycin, tetracycline, doxycycline, and pristinamycin) were determined using the Mycoplasma IST2 kit. Our study indicated that the overall prevalence of total Ureaplasma spp./M. hominis was 38.1% from 2013 to 2019. Ureaplasma spp. were the most frequently isolated species (overall prevalence, 31.3%), followed by Ureaplasma spp./M. hominis coinfection (6.0%) and single M. hominis infection (0.8%). The prevalence of Ureaplasma spp. and M. hominis was significantly higher in females than in males, and the highest positive rates of total Ureaplasma spp./M. hominis were observed in both female and male outpatients aged 14–20 years. During 2013–2019, josamycin, tetracycline, doxycycline, and pristinamycin maintained exceptionally high activity (overall resistance rates, <5%) against both Ureaplasma spp. and M. hominis, but ofloxacin and ciprofloxacin showed limited activity (overall resistance rates, >70%). During 1999–2019, the rates of resistance to ofloxacin and ciprofloxacin increased against both Ureaplasma spp. and M. hominis but decreased to erythromycin, clarithromycin, azithromycin, tetracycline, and doxycycline against Ureaplasma spp. In conclusion, our study demonstrates a high prevalence of Ureaplasma spp. compared to M. hominis and Ureaplasma spp./M. hominis, and their distribution was associated with sex and age. Josamycin, doxycycline, and tetracycline are promising antibiotics that have remarkable activity against Ureaplasma species and M. hominis. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520197/ /pubmed/36187990 http://dx.doi.org/10.3389/fmicb.2022.982429 Text en Copyright © 2022 Song, Wu, Kong, Jin, Yang, Xie and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Song, Jingjuan
Wu, Xuanlan
Kong, Yingying
Jin, Hong
Yang, Ting
Xie, Xinyou
Zhang, Jun
Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019
title Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019
title_full Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019
title_fullStr Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019
title_full_unstemmed Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019
title_short Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019
title_sort prevalence and antibiotics resistance of ureaplasma species and mycoplasma hominis in hangzhou, china, from 2013 to 2019
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520197/
https://www.ncbi.nlm.nih.gov/pubmed/36187990
http://dx.doi.org/10.3389/fmicb.2022.982429
work_keys_str_mv AT songjingjuan prevalenceandantibioticsresistanceofureaplasmaspeciesandmycoplasmahominisinhangzhouchinafrom2013to2019
AT wuxuanlan prevalenceandantibioticsresistanceofureaplasmaspeciesandmycoplasmahominisinhangzhouchinafrom2013to2019
AT kongyingying prevalenceandantibioticsresistanceofureaplasmaspeciesandmycoplasmahominisinhangzhouchinafrom2013to2019
AT jinhong prevalenceandantibioticsresistanceofureaplasmaspeciesandmycoplasmahominisinhangzhouchinafrom2013to2019
AT yangting prevalenceandantibioticsresistanceofureaplasmaspeciesandmycoplasmahominisinhangzhouchinafrom2013to2019
AT xiexinyou prevalenceandantibioticsresistanceofureaplasmaspeciesandmycoplasmahominisinhangzhouchinafrom2013to2019
AT zhangjun prevalenceandantibioticsresistanceofureaplasmaspeciesandmycoplasmahominisinhangzhouchinafrom2013to2019